Author:
Bruno Bezerra Jensen,Claudia Dantas Comandolli-Wyrepkowski,José Fernando Marques Barcellos,Aline Fagundes da Silva,Paula Figliuolo da Cruz Borges,Rebecca Sayuri Barbosa Hanada,Francimeire Gomes Pinheiro,Antonia Maria Ramos Franco
Reference30 articles.
1. Almeida GG, Fernandes FR, Ferreira WA, Vogas G, Bahia APCO, Demicheli C, Frezard FJG, Melo MN (2013). Amphiphilic antimonial complex: in vitro activity and efficacy of a topical formulation in a murine cutaneous leishmaniasis model. In: WL5 - World Congress on Leishmaniasis, 2013, Porto de Galinhas. Livro de Resumos, 235-236.
2. Brasil AMV, Franco AMR (2023). Aspectos epidemiolgicos da Leishmaniose Tegumentar Americana no Brasil em 2022. Peer Review 5(11):294-305.
3. Brasil (2017). Manual de Vigilncia da Leishmaniose Tegumentar Americana. Ministrio da Sade, Secretaria de Vigilncia em Sade. 2. ed. Braslia: Editora do Ministrio da Sade.
4. Carvalho SH, Frzard F, Pereira NP, Moura AS, Ramos LM, Carvalho GB, Rocha MO (2019). American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short?term possibilities for an alternative treatment. Tropical Medicine and International Health 24(4):380-391.
5. Comandolli-Wyrepkowski CD, Jensen BB, Grafova I, Santos PAD, Barros AMC, Soares FV, Barcellos JFM, Silva AF, Grafov A, Franco AMR (2017). Antileishmanial activity of extracts from Libidibia ferrea: development of in vitro and in vivo tests. Acta Amazonica 47:331-340.